ライフサイエンスコーパス: CK2

1 including GPCR kinases and casein kinase 2 (CK2).

2 tyrosine kinase activity of casein kinase 2 (CK2).

3 Western blotting to measure casein kinase 2 (CK2).

4 on of pERK, were unaffected by inhibition of CK2.

5 n1, as well as after NS5A phosphorylation by CK2.

6 otein complexes including the protein kinase CK2.

7 phorylation was confirmed using purified CK1/CK2.

8 on of wild-type and mutant KCNN3 channels by CK2.

9 horylated at serine 18 by the protein kinase CK2.

10 to Glu, SE) reduced Brg1 phosphorylation by CK2.

11 t on the crucial AIS protein, protein kinase CK2.

12 for association with MRE11 phosphorylated by CK2.

13 f casein kinase 1 (CK1) and casein kinase 2 (CK2) (10 muM D4476, 100 muM CK2-inhibitory peptide YNLKS

14 CD5 activates casein kinase 2 (CK2), a serine/threonine kinase that constitutively asso

15 at Brg1 is also a target of casein kinase 2 (CK2), a serine/threonine kinase, in proliferating myobla

16 require the Cka2 subunit of casein kinase 2 (CK2), a ubiquitous enzyme with multiple cellular functio

17 Casein kinase II (formerly known as CK2), a ubiquitous Ser/Thr kinase, plays critical roles

18 Here we show that CK2, a ubiquitous and constitutively active protein kina

19 ing proteins to interact with protein kinase CK2: (a) the alpha and beta subunits of the nicotinic ac

20 omotion and exploration at baseline, whereas CK2 ablation in D2 receptor-positive neurons caused incr

21 indings prompted us to examine the impact of CK2 ablation on the effects of l-DOPA treatment in the u

22 physiological significance of CD5-dependent CK2 activation in T cells, we generated a knock-in mouse

23 M1 spastins on FAT involve casein kinase 2 (CK2) activation.

24 In addition, CK2 activity controls the subcellular organization of in

25 In a number of animal tumors, CK2 activity has been shown to escape normal cellular co

26 n of Tyr 57 in H2A in yeast or inhibition of CK2 activity impairs transcriptional elongation in yeast

27 Both inhibitors alter CK2 activity in cells through inhibition of CK2 holoenzy

28 onfocal microscopy, here we demonstrate that CK2 activity is important for BTV replication.

29 CK2 activity is required for the interaction of FGF14 wi

30 We found that loss of CK2 activity reduced beta-catenin expression, a known MG

31 These results link CK2 activity with SG disassembly.

32 ination and cotyledon greening is reduced in CK2 alpha subunit mutants in an additive manner.

33 Taken together, these data suggest that CK2 alpha subunits affect diverse developmental and stre

34 he complexes at serine 424 by protein kinase CK2 (also known as casein kinase 2) activated the HDAC3

35 n of claudin-2 by targeting casein kinase 2 (CK2) also ameliorated colitis.

36 genetic ablation of the protein kinase CK2 (CK2) ameliorates experimental autoimmune encephalomyelit

37 ent actions of oxidative stress and elevated CK2 and ARF levels, which are common features of cancer

38 Downregulation of CK2 and EGFR also caused deactivation of heat shock prot

39 ll lines LN229 and U87MG that expressed both CK2 and EGFR at different levels were used.

40 nobioconjugate that is directed against both CK2 and EGFR.

41 he plasma membrane and was phosphorylated by CK2 and GSK3.

42 y in vitro seven bona fide sites modified by CK2 and GSK3beta kinases and two new sites on the PTEN C

43 te that two cascades of events controlled by CK2 and GSK3beta occur independently on two clusters of

44 RAS pathway proteins, including the kinases CK2 and p-ERK1/2 and the signaling scaffold KSR1.

45 e M-current, which is tonically regulated by CK2 and PP1 anchored to the KCNQ2 channel complex.

46 We also demonstrated that functional CK2 and protein phosphatase 1 (PP1) were selectively tet

47 ting subunit, as well as with protein kinase CK2 and protein phosphatase 2A, which modulate Ca(2+) se

48 on surface in MDC1 that is phosphorylated by CK2 and recognized by the DNA-damage response mediator p

49 f PRH on cell proliferation are abrogated by CK2 and that CK2 inhibits the binding of PRH at the Vegf

50 ce that Lac1 and Lag1 are direct targets for CK2 and that phosphorylation at conserved positions with

51 er regulator serine/threonine protein kinase CK2 and the wild-type/mutated epidermal growth factor re

52 ing epitopes of all four binding partners to CK2 and thereby gained insights into the potential role

53 ere secondary to PD-1-mediated inhibition of CK2 and were recapitulated by pharmacologic inhibition o

54 We focus on casein kinase 2 (CK2) and demonstrate that the regulatory (beta) and cata

55 S-CoV-2 infection promoted casein kinase II (CK2) and p38 MAPK activation, production of diverse cyto

56 I (MAF1), via a synergistic casein kinase 2 (CK2)- and mammalian target of rapamycin-dependent signal

57 ctins as targets of the protein kinases CK1, CK2, and PKA.

58 und Ca(2+) sensor calmodulin, protein kinase CK2, and protein phosphatase 2A.

59 ytosis, the kinase activities of MEK-ERK and CK2, and the presence of KSR1.

60 onsistent with the previous observation that CK2 appears enriched at the NMJ.

61 ory (beta) and catalytic (alpha) subunits of CK2 are essential for synapse maintenance.

62 ts of mutant M1 spastin on FAT, and identify CK2 as a critical mediator of these effects.

63 Our results identify CK2 as a new target of PD-1 and reveal an unexpected mec

64 Thus, these results identify CK2 as a nodal point in TH17 cell development and sugges

65 Our data implicate CK2 as a regulator of the Th17/Treg axis and Th17 cell m

66 Together, our data identify CK2 as an important regulator of sphingolipid metabolism

67 Taken together, these findings identify CK2 as an upstream activating kinase of PAK1, providing

68 fect of enhanced 5-HT4 receptor activity and CK2 as modulator of 5-HT4 receptor levels in this brain

69 sly, we demonstrated that the protein kinase CK2 associates with and phosphorylates the receptor tyro

70 ion site at serine 124, and we now show that CK2 associates with Foxc2 and phosphorylates this site i

71 confirmed direct phosphorylation of FGF14 by CK2 at S228 and S230, and mutation to alanine at these s

72 phosphorylation of TLE1 by casein kinase-2 (CK2) at Ser-239 and Ser-253 is necessary for its surviva

73 show that the 5-HT4 receptor is regulated by CK2, at transcriptional and post-transcriptional levels.

74 KCNQ3 anchor domains by protein kinase CK2 (CK2) augments binding, as previously shown for Nav1.2.

75 ery of at least four distinct kinases (PPKs, CK2, BIN2, and phytochrome itself) and four families of

76 nase that constitutively associates with the CK2-binding domain at the end of its cytoplasmic tail.

77 Casein kinase 2 (CK2) binds to the NHE3 C-terminus and constitutively pho

78 eals that CK2alpha, the catalytic subunit of CK2, binds across RNA-polymerase-II-transcribed coding g

79 ongly competes with Cl(-) uptake through CLC-ck2 but has no effect on CLC-ec1.

80 latelet-secreted kinases was enhanced, while CK2 but not CK1 inhibitors reduced APC cofactor activity

81 Inhibition of CK2 by siRNA or by pharmacological inhibitor restored No

82 Finally, inhibition of CK2 by TBBz or CK2 siRNA significantly enhances 1,25D(3)

83 the multitude of existing inhibitors against CK2, can serve as a structural basis for the design of n

84 sphorylation of calmodulin by protein kinase CK2 (casein kinase 2) rapidly and reversibly modulated K

85 al analyses demonstrated that protein kinase CK2-catalyzed phosphorylation of HDAC1 and -2 is crucial

86 on with selective inability to interact with CK2 (CD5DeltaCK2BD).

87 e found pharmacologic inhibition of the p38, CK2, CDK, AXL, and PIKFYVE kinases to possess antiviral

88 ll as genetic ablation of the protein kinase CK2 (CK2) ameliorates experimental autoimmune encephalom

89 2 and KCNQ3 anchor domains by protein kinase CK2 (CK2) augments binding, as previously shown for Nav1

90 orylated to nonphosphorylated protein kinase CK2 (CK2) substrate molecules, we employed (18)O-labeled

91 Biochemical studies demonstrate that the CK2 component of PRC1-AUTS2 neutralizes PRC1 repressive

92 ection also stimulated a marked induction of CK2-containing filopodial protrusions possessing budding

93 These results suggest that CK2 contributes to 1,25D(3)-mediated target gene express

94 e that phosphorylation by the protein kinase CK2 controls the biochemical activities of the bovine pa

95 f translation regulation, whereby mTORC1 and CK2 coordinate TC and eIF4F complex assembly to stimulat

96 shment of PRH function through inhibition of CK2 could be of value in treatment of myeloid leukaemias

97 is and Th17 cell maturation and suggest that CK2 could be targeted for the treatment of Th17 cell-dri

98 te PAK1 and that it is, rather, required for CK2-dependent PAK1(S223) phosphorylation that converts a

99 In particular, we observed that CK2-dependent phosphorylation of TIM(S1404) promotes nuc

100 ies show that DUSP6 serves as a scaffold for ck2-dependent PR-B Ser81 phosphorylation and subsequent

101 detected in MKs and platelets, the impact of CK2-dependent signaling on MK/platelet (patho-)physiolog

102 ailed to undergo phosphorylation on Ser81, a ck2-dependent site required for expression of these gene

103 ation in transcriptional elongation based on CK2-dependent tyrosine phosphorylation of the globular d

104 We have also noted that casein kinase 2 (CK2)-directed phosphorylation of Pax7 attenuates caspase

105 ive PACSIN 1 mutant, S358A, or inhibition of CK2 drastically reduces spine formation in neurons.

106 tive-feedback model in which a CRY-dependent CK2-driven posttranslational BMAL1-P-BMAL1 loop is an in

107 t phosphorylation of HDAC3 in the complex by CK2 during mitosis activates the complex for a dual role

108 recapitulated by pharmacologic inhibition of CK2 during TCR/CD3- and CD28-mediated stimulation withou

109 Exogenous expression of CK2 enhanced cell growth and tumor growth in mice, while

110 on XRCC1 phosphorylation by casein kinase 2 (CK2), enhancing XRCC1's interaction with the end resecti

111 In this article, we demonstrate that CK2 expression and kinase activity are induced upon CD4(

112 th in mice, while depletion or inhibition of CK2 expression decreased MB tumorigenesis.

113 To study the role of CK2 in MB we modulated CK2 expression in multiple MB cells.

114 in DNA damage-resistant cytoplasmic PTEN and CK2 expression, and the attenuation of DNA repair genes.

115 In cultured mammalian cells, reducing CK2 expression, but not its kinase activity, decreases t

116 These results suggest that a CK2-FGF14 axis may regulate Nav channels and neuronal ex

117 ed first by MEK and then by casein kinase 2 (CK2), followed by interaction with importin7 and subsequ

118 Together, this work reveals a novel CK2 function during the hyperosmotic stress response tha

119 polarization, but little is known about how CK2 functions in T cells.

120 We also showed that inhibition of CK2 greatly enhanced M3R-stimulated insulin secretion in

121 CK2 has enhanced expression or activity in numerous canc

122 Protein CK2 has gained much interest as an anticancer drug targe

123 UNX2 is required for bone formation and this CK2/HAUSP deubiquitination pathway offers therapeutic op

124 Here, we identify that a CK2/HAUSP pathway is a key regulator of RUNX2 stability,

125 This CK2/HAUSP/RUNX2 pathway is also necessary for HO, as its

126 and additionally, because both ceramides and CK2 have been implicated in the regulation of cancer, ou

127 Several crystal structures of human CK2 have been published with different conformations for

128 s not detectably affect the stability of the CK2 holoenzyme but correlates with the reduced occupancy

129 minal residues of CK2alpha, is essential for CK2 holoenzyme complex stability and function in vivo.

130 The CK2 holoenzyme consists of two catalytic alpha subunits

131 CK2 activity in cells through inhibition of CK2 holoenzyme formation.

132 value of 240nM and was shown to inhibit the CK2 holoenzyme-dependent phosphorylation of PDX-1, a sub

133 a/CK2beta interaction in vitro and inhibited CK2 in a substrate-selective manner.

134 idence for a critical role of protein kinase CK2 in controlling DNA replication initiation and the ex

135 Ablation of CK2 in D1 receptor-positive striatal neurons caused enha

136 on are bidirectionally modulated by ablating CK2 in D1- or D2-positive projection neurons, in male an

137 al in multiple cancers; however, the role of CK2 in MB is currently being studied.

138 In this study, we verified the importance of CK2 in MB tumorigenesis and discovered that inhibition o

139 To study the role of CK2 in MB we modulated CK2 expression in multiple MB cel

140 ent study, we demonstrate that inhibition of CK2 in pancreatic beta-cells, knockdown of CK2alpha expr

141 The role of CK2 in regulating MRP1 was confirmed in other cancer cel

142 The role of CK2 in regulation of NHE3 activity in polarized Caco-2/b

143 demonstrate a formerly undocumented role for CK2 in regulation of translation initiation, whereby CK2

144 n and stabilized an inactive conformation of CK2 in solution.

145 ion of dyskinesia reveals a central role for CK2 in striatal physiology and indicates that both pathw

146 ression of LID, the kinase CK2: knock-out of CK2 in striatonigral and striatopallidal neurons has opp

147 We report here that knock-out of CK2 in striatonigral neurons reduces the severity of l-D

148 In contrast, lack of CK2 in striatopallidal neurons enhances LID and ERK phos

149 CK2 in turn phosphorylates TIF-IA, thereby increasing rD

150 To study the importance of CK2 in vivo, we have selectively knocked out CK2, in eit

151 e uncover a novel role for casein kinase II (CK2) in the cellular response to hyperosmotic stress.

152 ults highlighted a role for casein kinase 2 (CK2) in the modulation of dopamine D1 receptor (D1R) sig

153 , PTEN is phosphorylated by casein kinase 2 (CK2) in the Ser380-Thr382-Thr383 cluster within the C-te

154 as a specific site used by casein kinase 2 (CK2) in vitro and in vivo.

155 A single kinase, CK2, in D1-MSNs significantly alters dopamine signaling,

156 CK2 in vivo, we have selectively knocked out CK2, in either D1- or D2-medium spiny neurons (MSNs) and

157 CK2 inactivation results in developmental defects that p

158 Moreover, pharmacological inhibition of CK2 increased myoblast proliferation.

159 ever, phosphorylation of PS by CK2 or by CK1/CK2 increased PS cofactor activity approximately 1.5-fol

160 ted by elevated levels of the protein kinase CK2, increases topo I activity and the cellular sensitiv

161 Mechanistically, both CK2 inhibition and the H2A(Y57F) mutation enhance H2B de

162 s confirmed in other cancer cell lines where CK2 inhibition decreased MRP1-mediated efflux of doxorub

163 r pretreatment with calyculin A Furthermore, CK2 inhibition diminished the medium after hyperpolariza

164 Furthermore, CK2 inhibition or genetic ablation prevents TH17 cell de

165 CK2 inhibition restores PTEN nuclear distribution and DN

166 ration of leukemia cells and synergizes with CK2 inhibition.

167 lles that are correctable by pharmacological CK2 inhibition.

168 Pretreatment of cells with the CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole revealed b

169 lation of CYP24A1 expression by 1,25D(3) and CK2 inhibitor enhances 1,25D(3)-mediated antitumor effec

170 sma membrane localization in the presence of CK2 inhibitor or shRNA targeting CK2alpha.

171 Treatment of wild-type MEFs with a CK2 inhibitor to block phosphorylation of the nuclear tr

172 CK2 inhibitor treatment suppressed M-current in rat supe

173 eatic islets with CX4945, a highly selective CK2 inhibitor, greatly reduced agonist-induced phosphory

174 nzotriazole (TBB), a potent casein kinase 2 (CK2) inhibitor, as a strong suppressor of FGF14:Nav1.6 i

175 Conversely, casein kinase-2 (CK2)-inhibitor increases Ikaros function thereby inhibit

176 They also suggest that CK2 inhibitors could release the full neuroprotective po

177 eno[1,2-b]indole-9,10-dione scaffold, potent CK2 inhibitors into selective ABCG2 inhibitors and vice

178 Thus, we identified a novel class of CK2 inhibitors targeting an allosteric pocket, offering

179 In the search for CK2 inhibitors, attention has expanded toward compounds

180 k inhibitors of CK2, whereas the most potent CK2 inhibitors, such as 4a, 4p, and 4e, displayed limite

181 ed aryl 2-aminothiazoles as a novel class of CK2 inhibitors, which displayed a non-ATP-competitive mo

182 o develop efficient and selective allosteric CK2 inhibitors.

183 s for future optimization of these promising CK2 inhibitors.

184 were synthesized as human casein kinase II (CK2) inhibitors.

185 casein kinase 2 (CK2) (10 muM D4476, 100 muM CK2-inhibitory peptide YNLKSKSSEDIDESS).

186 proliferation are abrogated by CK2 and that CK2 inhibits the binding of PRH at the Vegfr-1 promoter.

187 CK2 interacts with and phosphorylates the Hot1 transcrip

188 We found that CK2 interacts with Brg1, and mutation of putative phosph

189 Here, we asked whether CK2 interacts with other proteins involved in processes

190 Second, and even more surprisingly, CLC-ck2 is a Cl(-)/H(+) antiporter, even though it contains

191 CK2 is a constitutively active protein kinase overexpres

192 CK2 is a highly conserved and pleiotropic serine/threoni

193 Protein kinase CK2 is a serine/threonine kinase composed of two catalyt

194 CK2 is a ubiquitous Ser/Thr protein kinase involved in t

195 Casein kinase CK2 is an essential enzyme in higher organisms, catalyzi

196 Increased activity of protein kinase CK2 is associated with various types of cancer, neurodeg

197 CK2 is considered to be a constitutively active kinase a

198 Whereas CK2 is dispensable for miRNA biogenesis and the stabilit

199 Our findings show that CK2 is important for MB maintenance and that treatment w

200 ary, our findings reveal that protein kinase CK2 is involved in the regulation of CYP24A1 expression

201 the differential occupancy of tRNA genes by CK2 is likely to modulate its activation of RNA polymera

202 ation is reinforced by the observations that CK2 is responsible for epidermal growth factor-induced P

203 Ion selectivity in CLC-ck2 is similar to that in CLC-ec1, except that SO(4)(2-)

204 The protein kinase casein kinase 2 (CK2) is a pleiotropic and constitutively active kinase t

205 Casein kinase 2 (CK2) is known to regulate cell growth and survival in mu

206 Although protein kinase casein kinase 2 (CK2) is readily detected in MKs and platelets, the impac

207 S2 dephosphorylation and that, together with CK2, it regulates VIB morphology and virus replication.

208 player in the expression of LID, the kinase CK2: knock-out of CK2 in striatonigral and striatopallid

209 Furthermore, siRNA-mediated CK2 knockdown reduces 1,25D(3)-induced CYP24A1 mRNA expr

210 First, even though CLC-ck2 lacks conserved amino acids near the Cl(-)-binding s

211 Molecularly, inhibition of CK2 leads to reduced STAT3 phosphorylation and strongly

212 Remarkably, phosphorylated S164-SIRT1 and CK2 levels were also highly elevated in liver samples of

213 Proof-of-concept experiments using CK2-, MAPK- and EGFR-targeting assays in lung cancer cel

214 s, inhibition of phosphorylation of SIRT1 by CK2 may serve as a new therapeutic approach for treatmen

215 ious research suggests that casein kinase 2 (CK2) may be a promising therapeutic target for GBMs.

216 itro studies indicated that casein kinase 2 (CK2) mediated the phosphorylation of NS2, which regulate

217 n with p53 is modulated by casein kinase II (CK2)-mediated phosphorylation of a conserved acidic regi

218 Collectively, our findings suggest that CK2-mediated GluN2B phosphorylation contributes to incre

219 phorylation of beta-cell M3Rs, indicative of CK2-mediated M3R phosphorylation.

220 LRP6 receptor mutant (S1579A), deficient in CK2-mediated phosphorylation and Dab2 binding, fails to

221 tion of Mre11-S649 by Plk1 primed subsequent CK2-mediated phosphorylation at Mre11-serine 688 (S688).

222 Activation required reduced CK2-mediated phosphorylation near the eIF3d cap-binding

223 Our results indicate that CK2-mediated phosphorylation of Brg1 regulates myoblast

224 These findings suggest that CK2-mediated phosphorylation of calmodulin regulates the

225 CK2-mediated phosphorylation of calmodulin strengthened

226 that interaction of ECD with RUVBL1, and its CK2-mediated phosphorylation, independent of its interac

227 CK2 modulates Ca(2+) sensitivity of the channels by phos

228 altered activation of Hot1-targeted STL1 in ck2 mutants, resulting in a bimodal to unimodal shift in

229 have previously shown that casein kinase 2 (CK2) negatively regulates dopamine D1 and adenosine A2A

230 that increased activity of casein kinase 2 (CK2) observed in HPC and in MDSC could be responsible fo

231 rus (BPV) E2 protein, when phosphorylated by CK2 on two specific sites in the hinge, also loses its s

232 However, phosphorylation of PS by CK2 or by CK1/CK2 increased PS cofactor activity approxi

233 effects of chemical inhibition of Tyr kinase CK2 or by mutating the phosphorylation site.

234 Overexpression of CK2, particularly the alpha catalytic subunit (CK2alpha,

235 r recruitment, concurrently triggered by the CK2 phospho switch, provide an intriguing mechanism for

236 uppression was prevented by co-expression of CK2 phosphomimetic calmodulin mutants or pretreatment wi

237 CK2 phosphorylated 14-3-3gamma at serine residue 235 and

238 uggested that it is nuclear translocation of CK2-phosphorylated pERK that regulates cell proliferatio

239 The PNKP FHA domain binds to the CK2-phosphorylated XRCC4 C-terminal tail, while LigIV us

240 nd MRP1 interact physically, and recombinant CK2 phosphorylates MRP1-derived peptide in vitro in a Th

241 ator of RUNX2 stability, as Casein kinase 2 (CK2) phosphorylates RUNX2, recruiting the deubiquitinase

242 ur knowledge, the physiological relevance of CK2 phosphorylation of a GPCR and suggest the novel conc

243 atent viral DNA replication, indicating that CK2 phosphorylation of E2 is a negative regulator of vir

244 Recently it was proposed that CK2 phosphorylation of Maf1 is required for reactivation

245 CK2 phosphorylation of PACSIN 1 leads to a dissociation

246 perone family, whose actions are mediated by CK2 phosphorylation.

247 oes ubiquitin-mediated degradation primed by CK2 phosphorylation.

248 e and that their interaction is regulated by CK2 phosphorylation.

249 e polyanionic peptides typically produced by CK2 phosphorylation.

250 interaction is dependent on casein kinase 2 (CK2) phosphorylation of two acidic sequences within the

251 no terminus has a consensus casein kinase 2 (CK2) phosphorylation site at serine 124, and we now show

252 drial and nuclear proteins through consensus CK2, PKC phosphorylation, and N-myristoylation sites, an

253 and casein kinase1 (CK1) and casein kinase2 (CK2) positively and negatively regulates CREB-mediated t

254 the external glutamate gate (Glu(ex)) in CLC-ck2 prevents H(+) flux.

255 Protein kinase CK2 promotes cell survival and the activity of this kina

256 n experiments, we show that casein kinase 2 (CK2) promotes stress granule dynamics.

257 d serine/threonine kinase, casein kinase II (CK2), promotes miRISC function in Caenorhabditis elegans

258 The CK2 protein itself is required to negatively regulate mR

259 lity as a consequence of aberrantly elevated CK2 provoked by p53 ablation and irrevocably deregulated

260 ined insights into the potential role of the CK2/Rapsyn interaction.

261 it has been demonstrated that inhibitors of CK2 regressed tumor growth in GBM xenograft mouse models

262 The results reveal that CK2 regulates signaling events critical to LID in each o

263 orylates Tda1 to govern Tda1 activity, while CK2 regulates Tda1 nuclear localization.

264 The present study explored the impact of the CK2 regulatory beta-subunit on platelet biogenesis and a

265 abromobenzimidazole (TBBz), a protein kinase CK2 selective inhibitor as a disruptor of CYP24A1 promot

266 Accordingly, application of CK2-selective inhibitors suppressed KCNQ2 current.

267 Collectively, AMPK and CK2 signaling converge on histone kinase Tda1 to link ex

268 Finally, inhibition of CK2 by TBBz or CK2 siRNA significantly enhances 1,25D(3)-mediated antip

269 Mass spectrometry revealed a phosphorylated CK2 site at Thr37 within the N-terminal Gla-domain.

270 ced through phosphorylation of the canonical CK2 site within the SIM.

271 lso found that two putative casein kinase 2 (CK2) sites adjacent to IE2-SIM1 are phosphorylated in vi

272 expected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14/Fig4.

273 of phospho-site mutation and treatment with CK2 specific inhibitors demonstrated that phosphorylatio

274 t mutation of S30 in BRMS1 or the use of the CK2-specific small-molecule inhibitor CX4945 abrogates C

275 egulation of translation initiation, whereby CK2 stimulates phosphorylation of eIF2beta and simultane

276 TLR-dependent CK2 stimulation and subsequent RNA Pol III activation ar

277 DEAD-box RNA helicase, CGH-1/DDX6, as a key CK2 substrate within miRISC and demonstrate phosphorylat

278 ted to nonphosphorylated protein kinase CK2 (CK2) substrate molecules, we employed (18)O-labeled aden

279 opy-based assay that mimics the principle of CK2 subunit interaction by using CK2alpha1-335 and the f

280 nd identify novel non-peptidic inhibitors of CK2 subunit interface disclosing substrate-selective fun

281 Our studies demonstrate that the CK2 subunit, CK2alpha, is overexpressed in and has an im

282 However, the biological roles of CK2 subunits have not been fully characterized yet.

283 horylation was catalyzed by casein kinase 2 (CK2), the levels of which were dramatically elevated in

284 Inhibition of CK2 through TBB reduces the interaction of FGF14 with Na

285 tional complex consisting of PR-B, DUSP6 and ck2 to an enhancer region upstream of the Wnt1 promoter.

286 demonstrate that IP7, formed by IP6K2, binds CK2 to enhance its phosphorylation of the TTT complex, t

287 tify Ankyrin2 as a key presynaptic target of CK2 to maintain synapse stability.

288 pharmacologic inhibition of casein kinase 2 (CK2) to eradicate disease in high-risk B-cell acute lymp

289 ated by the Cka2 subunit of casein kinase 2 (CK2) to promote its E3 activity for Cse4.

290 eport an apoptotic signaling cascade linking CK2, TTT, the PIKKs, and p53.

291 Thus, S223 is likely accessible to CK2 upon conformational changes of PAK1 induced by GTPas

292 Targeting the catalytic activity of CK2 using the next-generation small molecule inhibitor C

293 origenesis and discovered that inhibition of CK2 using the small molecule inhibitor, CX-4945, can sen

294 tencies of our allosteric ligands to inhibit CK2 varied depending on the individual substrate.

295 , and 4k, behaved as very weak inhibitors of CK2, whereas the most potent CK2 inhibitors, such as 4a,

296 BDNF signaling PACSIN 1 is phosphorylated by CK2 which is essential for spine formation.

297 threonine 205 (Thr205), a consensus site for CK2, which appears to play a key regulatory role in modu

298 PHF8 is phosphorylated by CK2, which regulates binding of PHF8 to TopBP1.

299 Selective inhibitors of protein kinase CK2 with significant cytotoxicity on tumor cells based o

300 kinase Kns1, may regulate the association of CK2 with some of its substrates by phosphorylating Ckb1.